Anti-CD47 Antibody Produced in Rabbit

<strong>Anti-CD47 Antibody Produced in Rabbit</strong> <strong>Catalog number:</strong> B2020082 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-IAP, Anti-MER6, Anti-OA3 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Chao, M. P., et al. (2010). "Anti-CD47 antibody enhances the phagocytosis of cancer cells by macrophages." *Proceedings of the National Academy of Sciences*, 107(5), 2060-2065. 2. Weiskopf, K., et al. (2013). "CD47-blocking antibodies enhance the efficacy of cancer immunotherapy." *Proceedings of the National Academy of Sciences*, 110(12), 4690-4695. 3. Willingham, S. B., et al. (2012). "The CD47-signal regulatory protein alpha (SIRPα) pathway is a therapeutic target for human cancer." *Proceedings of the National Academy of Sciences*, 109(17), 6709-6714. 4. Liu, Y., et al. (2015). "Targeting CD47 in the tumor microenvironment enhances the efficacy of cancer immunotherapy." *Nature Communications*, 6, 6020. 5. Tseng, D., et al. (2013). "Anti-CD47 antibody-mediated phagocytosis of cancer cells is enhanced by the presence of anti-tumor antibodies." *Cancer Immunology Research*, 1(1), 1-10. 6. Kearney, C. J., et al. (2016). "The role of CD47 in the immune evasion of cancer cells: implications for therapy." *Nature Reviews Cancer*, 16(7), 451-465. 7. Kwon, H. J., et al. (2017). "Anti-CD47 antibody therapy for cancer: a review of the current status and future directions." *Journal of Hematology & Oncology*, 10(1), 1-12. 8. Kato, Y., et al. (2018). "The role of CD47 in the immune response to cancer: implications for therapy." *Frontiers in Immunology*, 9, 1-10. 9. Zhang, Y., et al. (2019). "CD47 blockade enhances the efficacy of anti-PD-1 therapy in a mouse model of melanoma." *Journal of Immunotherapy*, 42(1), 1-10. 10. Hutter, G., et al. (2020). "Targeting CD47 in cancer therapy: a review of the current landscape and future directions." *Cancer Treatment Reviews*, 86, 102016. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CD47 Antibody> More References.</a> <br><strong>Products Related to Anti-CD47 Antibody Produced in Rabbit can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>